Second negative report hits Intuitive Surgical, but shares rally on positive Goldman Sachs update

January 18, 2013 by MassDevice staff

The 2nd installment of a highly negative report on Intuitive Surgical by hedge fund Citron initially sent ISRG shares down more than 2% yesterday, until a price target increase by Goldman Sachs pushed investors into a 3% rally. Wall Street Beat

Shares of Intuitive Surgical (NSDQ:ISRG) came under pressure early yesterday on a negative report from hedge fund Citron Research, before rallying after Goldman Sachs boosted its price target on the stock.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.